Seeking small cap exposure | Maple-Brown Abbott

Home » Seeking small cap exposure

Seeking Australian
small cap exposure?

Australian small caps at an inflection point

We believe that 2025 has the potential to be the year of the Australian small cap given the cyclical and structural tailwinds in place.

From a cyclical perspective, Australian small caps are well supported by the positive global stimulatory backdrop and moderating domestic inflation outlook which is expected to result in lower interest rates. Historically, interest rate reductions have resulted in positive performance at the smaller end of the domestic equity market and is one of key catalysts we are looking for to see renewed investor interest this year. Given a more favourable domestic macroeconomic backdrop, we expect a better earnings outlook at the smaller end of the market (relative to large caps) over the next couple of years, resulting in a broadening out of stock performance across Australian small cap companies.

From a structural perspective, Australian small caps offer investors early-stage exposure to exciting growth opportunities in emerging industries as well as offering exposure to one of the few remaining inefficiently priced segments of the market to exploit. In addition, the domestic small caps landscape has evolved significantly over the past 15 years, with the index, S&P/ASX Small Ordinaries Index, now comprising of higher quality companies with strong balance sheets and improved earnings characteristics. These factors help support the case for a persistent Australian small cap active management premium.

In summary, we see emerging positive signs for Australian small caps given the number of tailwinds as risk appetite returns to the space after a challenging few years although investors need to be selective with selecting the right Australian small caps manager to exploit these opportunities.

About the Maple-Brown Abbott Australian Small Companies Fund

The Australian small cap manager with large institutional backing is now available to advisers.

The Maple-Brown Abbott Australian Small Companies Fund (the Fund) is managed by our experienced Australian small companies team, led by Co-Portfolio Managers Phillip Hudak and Matt Griffin. The Fund continues to generate what we consider to be strong returns since inception (24 June 2022), returning 20.5%*, outperforming the benchmark S&P/ASX Small Ordinaries Total Return Index by 10.3%* on an annualised basis. This follows on from the strategy’s strong performance over nine years at AMP Capital*, where the same ‘earnings drive share prices’ philosophy and investment process was applied.

* As at 31 January 2025.

View fund ratings and platform availability

Watch our capability video

Our investment philosophy

Rather than defining ourselves by a particular investment style, our investment philosophy is based on our belief that earnings drive share prices. Our three core beliefs underpinning the philosophy are:

share price performance is driven by medium-term earnings delivery with consideration given to valuation and where the company is in the earnings cycle;
sustainable business models, which include a company’s persistence of earnings over longer time periods, are an important driver of long-term performance and superior risk-reward characteristics; and
companies which disappoint on short-term earnings expectations typically underperform.

By taking time to understand where a company is in the earnings cycle, we can determine the price paid for the future earnings stream. Given the breadth of the Australian small cap market, we believe we can find undervalued companies where we have conviction in medium-term earnings delivery at any point of the market cycle.

Find out more

About our Australian Small Companies strategy and team
About the Maple-Brown Abbott Australian Small Companies Fund
About Maple-Brown Abbott

Our latest Investment Insights:

All weather portfolio

Capture ratios measure a portfolio’s return versus its performance benchmark during upward and downward market trends. In up markets, an upside capture ratio above 100% indicates a portfolio has outperformed its performance benchmark during periods of positive market returns.

A downside capture ratio below 100% indicates a portfolio has outperformed during periods of negative market returns. The Fund’s upside capture ratio of 97% shows Fund performance has typically kept pace with benchmark performance during periods of up markets. The Fund’s downside capture ratio of 48% shows the Fund has historically outperformed the benchmark by a significant margin during down markets.

These measures are indicators of a diverse, all-weather portfolio that is achieving its aim of delivering consistent results across market conditions and reflects the importance we place on risk management by aiming to minimise downside risk while participating in the upside.

Capture ratios – upside and downside

Source: MBA, data since inception of the MBA Australian Small Companies Fund (24 June 2022) to 31 March 2025. Benchmark is the S&P/ASX Small Ordinaries (Total Return) Index. Performance is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign income tax offsets are not included in the performance figures. Past performance is not a reliable indicator of future performance.

Average monthly performance in rising markets

Source: MBA, data since inception of the MBA Australian Small Companies Fund (24 June 2022) to 31 March 2025. Benchmark is the S&P/ASX Small Ordinaries (Total Return) Index. Performance is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign income tax offsets are not included in the performance figures. Past performance is not a reliable indicator of future performance.

Average monthly performance in falling markets

Source: MBA, data since inception of the MBA Australian Small Companies Fund (24 June 2022) to 31 March 2025. Benchmark is the S&P/ASX Small Ordinaries (Total Return) Index. Performance is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign income tax offsets are not included in the performance figures. Past performance is not a reliable indicator of future performance.

Fund rating and platform availability

Platform availability

AMP North
BT Panorama
CFS Edge
CFS Wrap
HUB24
Netwealth

Rating/recommendation

Lonsec
The Lonsec rating issued 10/2024 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. ©2024 Lonsec. All rights reserved.

Morningstar Medalist Rating(TM)
Assigned as of 08/01/25
Analyst Driven % 100
Data Coverage % 100

Fund Maple-Brown Abbott Australian Small Companies received a Morningstar Medalist Rating(TM) of ‘Silver’ on 08/01/25.

©2025 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report or data has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Morningstar’s publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser.

Zenith
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned MPL1241AU February 2024) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.

* The past performance and experience of the portfolio managers was achieved managing a different fund with substantially the same investment strategy as the Fund. Past performance is not a reliable indicator of future performance.
This information was prepared and issued by Maple-Brown Abbott Ltd ABN 73 001 208 564, Australian Financial Service Licence No. 237296 (“MBA”). This information does not constitute investment advice or an investment recommendation of any kind and should not be relied upon as such. This information is general information only and it does not have regard to any person’s investment objectives, financial situation or needs. Before making any investment decision, you should seek independent investment, legal, tax, accounting or other professional advice as appropriate, and obtain the relevant Product.

Fund performance^

as at 31/03/2025

asdate	blank	1 mth %	3 mths %	Calendar year to date	1 yr % p.a.	Since inception % p.a.*
31/03/2025	Fund	-2.0	1.7	1.70	10.6	17.6
31/03/2025	Benchmark	-3.6	-2.0	-2.00	-1.3	7.1
31/03/2025	Difference	1.6	3.7	3.70	11.9	10.6

^Past performance is not a reliable indicator of future performance. No warranty can be given for future performance. Returns are volatile and may fluctuate quickly and significantly. Total return is based on the movement in net asset value per unit plus distributions and is before tax and after all fees and charges. Imputation and foreign income tax offsets are not included in the performance figures.
Source: Maple-Brown Abbott and S&P
*Inception date is 24 June 2022

A team of experienced and dedicated
investment professionals.

Co-Portfolio Manager, Australian Small Companies

Phillip Hudak

BBus, CFA
Phillip Hudak joined Maple-Brown Abbott in April 2022 as Co-Portfolio Manager for Australian Small Companies, bringing over 20 years’ investment experience, with 15 years dedicated to Australian small cap equity portfolio management and fundamental stock research. In his current role, Phillip is responsible for leading the Australian small companies equity business, focusing on medium-term earnings delivery combined with a differentiated market-leading sustainability framework which is designed to outperform in most market environments.

Before joining Maple-Brown Abbott, Phillip worked as Co-Portfolio Manager on the AMP Capital Australian Emerging Companies strategy for nine years. Prior to that, he was a small companies analyst at ING Investment Management, analyst at MIR Investment Management and an investment consultant with Russell Investment Group.

Co-Portfolio Manager, Australian Small Companies

Matt Griffin

BCom
Matt Griffin joined Maple-Brown Abbott in April 2022 as Co-Portfolio Manager for Australian Small Companies, bringing 14 years’ investment experience in Australian small cap equity portfolio management and fundamental stock research. In his current role, he is responsible for leading the Australian small companies equity business, focusing on medium-term earnings delivery combined with a differentiated market-leading sustainability framework which is designed to outperform in most market environments.

Before joining Maple-Brown Abbott, Matt worked as Co-Portfolio Manager on the AMP Capital Australian Emerging Companies strategy for four years. Prior to that, he was Investment Director at IFM Investors, where he was integral to the launch of the IFM Australia small caps and micro caps strategy, and a small companies analyst at Macquarie Asset Management.

Investment Analyst, Australian Small Companies

William Hanna

BCom, LLB
William Hanna joined Maple-Brown Abbott in July 2022 as Investment Analyst, Australian Small Companies. A key focus of William’s role is to conduct detailed stock research and analysis of Australian small cap companies, as well as support the portfolio managers in the Australian Small Companies team.

Before joining Maple-Brown Abbott, William worked as Investment Analyst at JANA, a leading investment consultant, focused on Australian Equities and REITs research as well as providing investment strategy advice to institutional funds.

ESG Investment Analyst

Ayesha Azeem

BEc
Ayesha joined Maple-Brown Abbott in October 2022 as an ESG Investment Analyst. In her current role, she is responsible for conducting environmental, social and governance (ESG) stock research and analysis for Australian small cap companies as well as supporting broader ESG efforts. Before joining Maple-Brown Abbott, Ayesha worked as an assistant investment analyst in the global equities team at Pendal Group, covering the consumer staples and chemicals sectors across North America, Europe and Japan.

Contact us

Vijay Srinivasan
Head of Intermediary Distribution

E vsrinivasan@maple-brownabbott.com
T +61 2 8226 6238
M +61 403 046 832

Alternatively, contact

Subscribe to receive Investment Insights

Please confirm your location

Your location

Terms and conditions

        Maple-Brown Abbott may make changes to the Terms from time to time without prior notice to you. By continuing to access this website, you are deemed to have accepted such changes and that Maple-Brown Abbott has no obligation to notify you of any such changes.
        
        Investors outside of Australia

        Access to this website may be restricted by law in certain jurisdictions. Maple-Brown Abbott does not make any representation that the use of this information is permitted in locations other than Australia.
         
        Information on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Maple-Brown Abbott or its associated parties to any registration or other requirement within that jurisdiction or country.
        
        No U.S. Persons

        The information on this website is not available to US persons, as defined under Regulation S of the U.S. Securities Act of 1933, as amended (US Person). As such by accepting these Terms you represent and warrant that you: (i) are not a US Person; (ii) are not acting on for the account or benefit of any US Person; and (iii) will not provide or otherwise make available any information herein to any US Person.
        
        Limit of liability
        
        The information is believed to be accurate at the time of compilation and is provided by Maple-Brown Abbott in good faith. However, the use of this website is at your sole risk. Maple-Brown Abbott makes no representation or warranty as to the quality, completeness, accuracy, reliability, timeliness or currency of information contained on this website.
         
        To the full extent permitted by law, Maple-Brown Abbott and their associated parties exclude all liability for any direct or indirect loss or damage arising in any way from errors or omissions in the information on this website, and exclude all responsibility for any direct or indirect loss or damage arising in any way as a result of any person using this website or relying on, using or downloading anything from this website.
         
        Liability for negligence, breach of contract, or contravention of any law as a result of a failure to provide this information, or any part of it, or for any problems with this information, which cannot be lawfully excluded, is limited, at Maple-Brown Abbott’s option, and to the maximum extent permitted by law, to resupplying this information or any part of it to you, or paying for the resupply of this information or any part of it to you.
         
        Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott accepts no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.
        
        Current offer document

        The provision of material on this website is not an invitation to enter into any legal agreement of any kind. Maple-Brown Abbott is the product issuer. The information on this website does not constitute an offer, a recommendation, or invitation to invest in any investments, securities or financial products of Maple-Brown Abbott. The offer to invest in a Mable-Brown Abbott financial product will be made in a copy of the offer document, the Product Disclosure Statement and Additional Information Booklet (together, PDS) or prospectus, either downloaded from this website or provided by us in hard copy form. The PDS or other disclosure document and the Target Market Determination for the relevant financial product should be considered before deciding whether to acquire or continue to hold units in that financial product.
        
        General information

        This website provides general information about Maple-Brown Abbott and the investment vehicles which it manages/operates. The information on this website does not provide any financial product or investment advice. It should not be construed as a recommendation to invest in any particular financial product offered by Maple-Brown Abbott.
         
        Neither Maple-Brown Abbott nor its associated parties make any representation nor give any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any financial product shown on this website.
         
        The information on this website does not take into account the investment objectives, financial situation or particular needs of any person and should not be used as the basis for making investment, financial or other decisions. We do not give advice in relation to any particular investment, security or financial product offered by Maple-Brown Abbott or any associated parties. Before making an investment decision, you should obtain and consider the relevant PDS, and you should seek independent advice and consider whether an investment is appropriate in light of your particular investment needs, objectives and financial circumstances.
        
        Past performance

        Past performance is not a reliable indicator of future performance. Investment is subject to certain risks including the loss of capital invested. Unless otherwise stated, all figures and amounts displayed on this website are in Australian dollars. All asset values are based on our most recent valuations. As pricing frequencies and valuation methodologies differ for the various types of assets, the asset values shown may not be current and, therefore, you shouldn’t rely on them as the basis for trading investments in your account. Returns are volatile and may fluctuate quickly and significantly.
        
        Market Highlights

        The views expressed in any articles are the author’s alone. They should not be otherwise attributed. These views are current as at the date of production and can change day to day. Maple-Brown Abbott may or may not hold securities mentioned.
        
        Intellectual property rights, trademarks and copyright

        Copyright, trademarks, intellectual property rights, database rights and all similar rights in this website and the information contained in it are owned by Maple-Brown Abbott or its associated parties. You may use the information on this website and reproduce it in hardcopy for your own personal reference only provided that you do not remove any copyright notices, disclaimers or any Maple-Brown Abbott trademarks or logos. Except for this purpose or as permitted by law, none of the information on this website may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the express written consent of Maple-Brown Abbott or, in the case of third party material, from the owner of the copyright in that material.
        
        Links to and from other websites

        This website may contain links to other websites. Neither Maple-Brown Abbott, nor any associated party make any representation or warranty as to the accuracy, quality, currency or any other aspect of the information contained in those linked websites. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott or any associated party of the goods or services offered on that other website or the information contained in that other website. You agree that you will not create any link to any page within this website without Maple-Brown Abbott's express written permission.
        
        Privacy, records and cookies

        You authorise Maple-Brown Abbott to keep records of your access to this website and to utilise cookies, including placing cookies on your computer, during your access to this website.
         
        You acknowledge and agree that the collection, disclosure and/or use of information about you from accessing this website will be subject to the terms of Maple-Brown Abbott's Privacy Policy.
        
        Governing law

        These Terms are governed by the laws applicable in the State of New South Wales, Australia and each party irrevocably submits to the non-exclusive jurisdiction of the courts of that State.
        
        Internet

        Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott accepts no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.

           Important Disclaimers
 
            By accessing or using this website of Maple-Brown Abbott Limited and its affiliates (collectively “Maple-Brown Abbott” or “we”), you hereby accept and agree to comply with these Terms of Use. Maple-Brown Abbott is an investment adviser registered with the United States Securities and Exchange Commission under the Investment Advisers Act of 1940. Such registration does not imply a certain level of skill or training.
             
            Maple-Brown Abbott’s clients in the United States are institutional investors, and we will provide prospective investors with a copy of our current Form ADV, Parts 2A and 2B prior to engagement. Prospective investors may obtain a copy of these disclosures on the SEC website at http://adviserinfo.sec.gov.
             
            The content on this website has been prepared for general information purposes only and is provided solely to gain an understanding of our investment philosophy, our strategies and to be able to contact us for further information. The content has no regard to the specific investment objectives, financial situation or particular needs of any specific recipient. The information on this website is not intended as and does not constitute investment advice or an offer of investment advice, legal or tax advice, an offer to sell any securities to any person or a solicitation of any person of any offer to purchase any securities. The information should not be construed as Maple-Brown Abbott’s endorsement, recommendation or sponsorship of any company or security.
             
            There are inherent risks in relying on, using or retrieving information from this website, including but not limited to the risk that any such information is or becomes untimely, is or becomes erroneous due to technical or other errors, is incomplete, and/or other risks related to the display, source or accuracy of the information, including risks that may be currently unknown to Maple-Brown Abbott. This website, the information and materials contained on this website, including text, graphics, software, links and other items, are provided “as is” and “as available.” Maple-Brown Abbott does not warrant the accuracy, adequacy, completeness, timeliness or availability of this website. You should carefully evaluate all information found on this website, and you should seek the advice of professionals, as appropriate, to evaluate any data, information, product or service. Past performance is not indicative of future results, and investing in securities involves risk of loss. Further, any benchmarks are provided for illustrative purposes only and should not be relied upon as an accurate measure of comparison. Indices are unmanaged and investors cannot directly invest in them. They are not subject to expenses or fees and are often comprised of securities and other investment instruments the liquidity of which is not restricted. The investment activities and performance of any strategy referred to on this website may be considerably more volatile than the performance of any benchmark index.
             
            In no event will Maple-Brown Abbott be liable for any damages, including, without limitation, direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with this website or use thereof or the inability by any party to use this website, or in connection with any failure of performance, error, omission, interruption, defect, delay in operation or transmission, computer virus or technical or system failure, even if Maple-Brown Abbott, or representatives thereof, are advised of the possibility of such damages, losses or expenses.
             
            This content may not be reproduced or copied by any means without the prior consent of Maple-Brown Abbott. The content is based on information obtained from sources believed to be reliable but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the content. This website may include links to third-party websites. Maple-Brown Abbott does not make any representations or guarantees as to the information obtained from such links, including their accuracy, timeliness, suitability, or completeness. By accessing a linked third-party website, you do so at your own risk. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott or any of its affiliates of the goods or services offered on that other website or the information contained in that other website. Any opinions expressed in the content are subject to change without notice, and Maple-Brown Abbott is under no obligation to update or keep current the information.
             
            Maple-Brown Abbott may make changes to these Terms of Use from time to time without prior notice to you. By continuing to access the website, you are deemed to have accepted such changes.

Acceptance of terms and conditions
 
            This website is owned and operated by Maple-Brown Abbott Limited ABN 73 001 208 564 (AFSL 237296) (Maple-Brown Abbott or we). By accessing this website you agree to the following terms and conditions (the Terms) and acknowledge that you have read and understood them. In addition to these Terms, you agree that your access to this website is also subject to any other notices, disclaimers or statements contained on this website.
             
            Maple-Brown Abbott may make changes to the Terms from time to time without prior notice to you. By continuing to access this website, you are deemed to have accepted such changes and that Maple-Brown Abbott has no obligation to notify you of any such changes.
             
            New Zealand investors
            
            This website includes documents and information relating to financial products that is directed at wholesale clients (as defined in the Financial Markets Conduct Act 2013). This information is not intended to be distributed or passed on, directly or indirectly, to any other class of persons in New Zealand. It is being supplied to wholesale clients solely for their information and may not be reproduced, forwarded to any other person or published, in whole or in part, for any purpose.
            
            Investors outside of Australia and New Zealand 
            
            Access to this website may be restricted by law in certain jurisdictions. Maple-Brown Abbott does not make any representation that the use of this information is permitted in locations other than Australia and New Zealand.
             
            Information on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Maple-Brown Abbott or its associated parties to any registration or other requirement within that jurisdiction or country.
             
            No U.S. Persons
             
            The information on this website is not available to US persons, as defined under Regulation S of the U.S. Securities Act of 1933, as amended (US Person). As such by accepting these Terms you represent and warrant that you: (i) are not a US Person; (ii) are not acting on for the account or benefit of any US Person; and (iii) will not provide or otherwise make available any information herein to any US Person. 
             
            Limit of liability
             
            The information is believed to be accurate at the time of compilation and is provided by Maple-Brown Abbott in good faith. However, the use of this website is at your sole risk. Maple-Brown Abbott makes no representation or warranty as to the quality, completeness, accuracy, reliability, timeliness or currency of information contained on this website.
             
            To the full extent permitted by law, Maple-Brown Abbott and their associated parties exclude all liability for any direct or indirect loss or damage arising in any way from errors or omissions in the information on this website, and exclude all responsibility for any direct or indirect loss or damage arising in any way as a result of any person using this website or relying on, using or downloading anything from this website.
             
            Liability for negligence, breach of contract, or contravention of any law as a result of a failure to provide this information, or any part of it, or for any problems with this information, which cannot be lawfully excluded, is limited, at Maple-Brown Abbott’s option, and to the maximum extent permitted by law, to resupplying this information or any part of it to you, or paying for the resupply of this information or any part of it to you.
             
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott accepts no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.
             
            Current offer document
             
            The provision of material on this website is not an invitation to enter into any legal agreement of any kind. Maple-Brown Abbott is the product issuer. The information on this website does not constitute an offer, a recommendation, or invitation to invest in any investments, securities or financial products of Maple-Brown Abbott. The offer to invest in a Mable-Brown Abbott financial product will be made in a copy of the offer document, the Product Disclosure Statement and Additional Information Booklet (together, PDS) or prospectus, either downloaded from this website or provided by us in hard copy form. The PDS or other disclosure document and the Target Market Determination for the relevant financial product should be considered before deciding whether to acquire or continue to hold units in that financial product.
             
            General information 
             
            This website provides general information about Maple-Brown Abbott and the investment vehicles which it manages/operates. The information on this website does not provide any financial product or investment advice. It should not be construed as a recommendation to invest in any particular financial product offered by Maple-Brown Abbott.
             
            Neither Maple-Brown Abbott nor its associated parties make any representation nor give any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any financial product shown on this website.
             
            The information on this website does not take into account the investment objectives, financial situation or particular needs of any person and should not be used as the basis for making investment, financial or other decisions. We do not give advice in relation to any particular investment, security or financial product offered by Maple-Brown Abbott or any associated parties. Before making an investment decision, you should obtain and consider the relevant PDS, and you should seek independent advice and consider whether an investment is appropriate in light of your particular investment needs, objectives and financial circumstances.
             
            Past performance
             
            Past performance is not a reliable indicator of future performance. Investment is subject to certain risks including the loss of capital invested. Unless otherwise stated, all figures and amounts displayed on this website are in Australian dollars. All asset values are based on our most recent valuations. As pricing frequencies and valuation methodologies differ for the various types of assets, the asset values shown may not be current and, therefore, you shouldn’t rely on them as the basis for trading investments in your account. Returns are volatile and may fluctuate quickly and significantly.
             
            Market Highlights
             
            The views expressed in any articles are the author’s alone. They should not be otherwise attributed. These views are current as at the date of production and can change day to day. Maple-Brown Abbott may or may not hold securities mentioned. 
             
            Intellectual property rights, trademarks and copyright
             
            Copyright, trademarks, intellectual property rights, database rights and all similar rights in this website and the information contained in it are owned by Maple-Brown Abbott or its associated parties. You may use the information on this website and reproduce it in hardcopy for your own personal reference only provided that you do not remove any copyright notices, disclaimers or any Maple-Brown Abbott trademarks or logos. Except for this purpose or as permitted by law, none of the information on this website may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the express written consent of Maple-Brown Abbott or, in the case of third party material, from the owner of the copyright in that material.
             
            Links to and from other websites
             
            This website may contain links to other websites. Neither Maple-Brown Abbott, nor any associated party make any representation or warranty as to the accuracy, quality, currency or any other aspect of the information contained in those linked websites. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott or any associated party of the goods or services offered on that other website or the information contained in that other website. You agree that you will not create any link to any page within this website without Maple-Brown Abbott's express written permission.
             
            Privacy, records and cookies
             
            You authorise Maple-Brown Abbott to keep records of your access to this website and to utilise cookies, including placing cookies on your computer, during your access to this website.
             
            You acknowledge and agree that the collection, disclosure and/or use of information about you from accessing this website will be subject to the terms of Maple-Brown Abbott's Privacy Policy.
             
            Governing law
             
            These Terms are governed by the laws applicable in the State of New South Wales, Australia and each party irrevocably submits to the non-exclusive jurisdiction of the courts of that State.
             
            Internet
             
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott accepts no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.

           Acceptance of UCITS terms and conditions

            This section of the website (UCITS website) has been prepared by Maple-Brown Abbott Limited (ABN 73 001 208 564 AFSL 237296 ) (Maple-Brown Abbott or we) on behalf of Maple-Brown Abbott Funds plc (MBA Funds). The UCITS website is owned and operated by Maple-Brown Abbott. By accessing the UCITS website you agree to the following terms and conditions (the UCITS Terms) and acknowledge that you have read and understood them. In addition to these UCITS Terms, you agree that your access to this UCITS website is also subject to any other notices, disclaimers or statements contained on this UCITS website.
            
            Maple-Brown Abbott may make changes to the UCITS Terms from time to time without prior notice to you. By continuing to access the UCITS website, you are deemed to have accepted such changes and that Maple-Brown Abbott has no obligation to notify you of any such changes.
            
            Restrictions on information
            
            Access to the UCITS website may be restricted by law in certain jurisdictions. Neither Maple-Brown Abbott nor MBA Funds make any representation that the use of this information is permitted in locations other than Ireland or jurisdictions in which MBA Funds is registered for sale. 
            
            This information on the UCITS website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Maple-Brown Abbott, MBA Funds or their associated parties to any registration or other requirement within that jurisdiction or country.
            
            When using the UCITS website, you are responsible for complying with all applicable local, national and international laws and regulations, including those related to data privacy and intellectual property.  It may be illegal to access or download the information contained in the UCITS website in certain jurisdictions and we disclaim all responsibility if you access or download any information in breach of any law or regulation applicable to you or in the place that you access the UCITS website.
            
            No U.S. Persons
            
            The information on this UCITS website is not available to US persons, as defined under Regulation S of the U.S. Securities Act of 1933, as amended (US Person). As such by accepting these UCITS Terms you represent and warrant that you: (i) are not a US Person; (ii) are not acting on for the account or benefit of any US Person; and (iii) will not provide or otherwise make available any information herein to any US Person.
            
            Limit of liability
            
            The information is believed to be accurate at the time of compilation and is provided by Maple-Brown Abbott and MBA Funds in good faith. However, the use of the UCITS website is at your sole risk. Neither Maple-Brown Abbott nor MBA Funds make any representation or warranty as to the quality, completeness, accuracy, reliability, timeliness or currency of information contained in the UCITS website.
            
            To the full extent permitted by law, Maple-Brown Abbott, MBA Funds and their associated parties exclude all liability for any direct or indirect loss or damage arising in any way from errors or omissions in the information in the UCITS website, and exclude all responsibilities for any direct or indirect loss or damage arising in any way as a result of any person using the UCITS website or relying on, using or downloading anything from the UCITS website.
            
            Liability for negligence, breach of contract, or contravention of any law as a result of a failure to provide this information, or any part of it, or for any problems with this information, which cannot be lawfully excluded, is limited, at Maple-Brown Abbott’s and/ or MBA Funds’ option, and to the maximum extent permitted by law, to resupplying this information or any part of it to you, or paying for the resupply of this information or any part of it to you.
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accept no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.
            
            Current Prospectus
            
            The provision of material on the UCITS website is not an invitation to enter into any legal agreement of any kind. No statement or information in the UCITS website constitutes an offer, recommendation, invitation to invest in any investments, securities or financial products of MBA Funds.
            
            Should you wish to invest directly in a MBA Funds financial product referred to in the UCITS website you must only do so on the basis of a current prospectus (including any addenda thereto), application form and key investor information document (KIID) either downloaded from the UCITS website or provided by us in hard copy form.
            
            No guarantees or financial advice
            
            This UCITS website provides general information about MBA Funds only, it does not provide any financial product or investment advice. It should not be construed as a recommendation to invest in any particular financial product on the UCITS website. 
            
            Neither Maple-Brown Abbott, MBA Funds nor their associated parties make any representation nor give any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any financial product shown on this UCITS website. Investment is subject to certain risks. Possible risks could include delays in repayment and loss of income or capital invested. 
            
            This UCITS website does not take into account the investment objectives, financial situation or particular needs of any person and should not be used as the basis for making investment, financial or other decisions. We do not give advice in relation to any particular investment, security or financial product offered by MBA Funds or any associated parties. Before making an investment decision, you should obtain and consider the relevant prospectus (including any addenda thereto) and KIID, and you should seek independent advice and consider whether an investment is appropriate in light of your particular investment needs, objectives and financial circumstances. 
            
            Past performance
            
            Past performance is not a reliable indicator of future performance. Investment is subject to certain risks including the loss of capital invested. All asset values are based on our most recent valuations. As pricing frequencies and valuation methodologies differ for the various types of assets, the asset values shown may not be current and, therefore, you shouldn’t rely on them as the basis for trading investments in your account. Returns are volatile and may fluctuate quickly and significantly.
            
            Changes in exchange rates may have an adverse effect on the value price or income of a sub fund of MBA Funds or any class thereof.
            
            Market highlights
            
            The views expressed in any articles are the author’s alone. They should not be otherwise attributed. These views are current as at the date of production and can change day to day. Maple-Brown Abbott and/or MBA Funds may or may not hold securities mentioned. 
            
            Intellectual property rights, trademarks and copyright
            
            Copyright, trademarks, intellectual property rights, database rights and all similar rights in this UCITS website and the information contained in it are owned by Maple-Brown Abbott, MBA Funds or their associated parties. You may use the information on this UCITS website and reproduce it in hardcopy for your own personal reference only provided that you do not remove any copyright notices, disclaimers or any Maple-Brown Abbott trademarks or logos. Except for this purpose or as permitted by law, none of the information on this UCITS website may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the express written consent of Maple-Brown Abbott or, in the case of third party material, from the owner of the copyright in that material.
            
            Links to and from other websites
            
            The UCITS website may contain links to other websites. Neither Maple-Brown Abbott, MBA Funds, nor any associated party make any representation or warranty as to the accuracy, quality, currency or any other aspect of the information contained in those linked websites. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott, MBA Funds or any associated party of the goods or services offered on that other website or the information contained in that other website. You agree that you will not create any link to any page within the UCITS website without Maple-Brown Abbott's express written permission.
            
            Privacy, records and cookies
            
            You authorise us to keep records of your access to the UCITS website and to utilise cookies, including placing cookies on your computer, during your access to the UCITS website.
            
            You acknowledge and agree that the collection, disclosure, processing and/or use of information about you from accessing the UCITS website will be subject to the Data Privacy Statement.
            
            Governing law
            
            These UCITS Terms are governed by the laws applicable in Ireland and each party irrevocably submits to the non-exclusive jurisdiction of the courts of Ireland.
            
            Internet
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accept no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.

            Acceptance of UCITS terms and conditions

            This section of the website (UCITS website) has been prepared by Maple-Brown Abbott Limited (ABN 73 001 208 564 AFSL 237296 ) (Maple-Brown Abbott or we) on behalf of Maple-Brown Abbott Funds plc (MBA Funds). The UCITS website is owned and operated by Maple-Brown Abbott. By accessing the UCITS website you agree to the following terms and conditions (the UCITS Terms) and acknowledge that you have read and understood them. In addition to these UCITS Terms, you agree that your access to this UCITS website is also subject to any other notices, disclaimers or statements contained on this UCITS website.
            
            Maple-Brown Abbott may make changes to the UCITS Terms from time to time without prior notice to you. By continuing to access the UCITS website, you are deemed to have accepted such changes and that Maple-Brown Abbott has no obligation to notify you of any such changes.
            
            Restrictions on information
            
            Access to the UCITS website may be restricted by law in certain jurisdictions. Neither Maple-Brown Abbott nor MBA Funds make any representation that the use of this information is permitted in locations other than Ireland or jurisdictions in which MBA Funds is registered for sale. 
            
            This information on the UCITS website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Maple-Brown Abbott, MBA Funds or their associated parties to any registration or other requirement within that jurisdiction or country.
            
            When using the UCITS website, you are responsible for complying with all applicable local, national and international laws and regulations, including those related to data privacy and intellectual property.  It may be illegal to access or download the information contained in the UCITS website in certain jurisdictions and we disclaim all responsibility if you access or download any information in breach of any law or regulation applicable to you or in the place that you access the UCITS website.
            
            No U.S. Persons
            
            The information on this UCITS website is not available to US persons, as defined under Regulation S of the U.S. Securities Act of 1933, as amended (US Person). As such by accepting these UCITS Terms you represent and warrant that you: (i) are not a US Person; (ii) are not acting on for the account or benefit of any US Person; and (iii) will not provide or otherwise make available any information herein to any US Person.
            
            Limit of liability
            
            The information is believed to be accurate at the time of compilation and is provided by Maple-Brown Abbott and MBA Funds in good faith. However, the use of the UCITS website is at your sole risk. Neither Maple-Brown Abbott nor MBA Funds make any representation or warranty as to the quality, completeness, accuracy, reliability, timeliness or currency of information contained in the UCITS website.
            
            To the full extent permitted by law, Maple-Brown Abbott, MBA Funds and their associated parties exclude all liability for any direct or indirect loss or damage arising in any way from errors or omissions in the information in the UCITS website, and exclude all responsibilities for any direct or indirect loss or damage arising in any way as a result of any person using the UCITS website or relying on, using or downloading anything from the UCITS website.
            
            Liability for negligence, breach of contract, or contravention of any law as a result of a failure to provide this information, or any part of it, or for any problems with this information, which cannot be lawfully excluded, is limited, at Maple-Brown Abbott’s and/ or MBA Funds’ option, and to the maximum extent permitted by law, to resupplying this information or any part of it to you, or paying for the resupply of this information or any part of it to you.
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accept no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.
            
            Current Prospectus
            
            The provision of material on the UCITS website is not an invitation to enter into any legal agreement of any kind. No statement or information in the UCITS website constitutes an offer, recommendation, invitation to invest in any investments, securities or financial products of MBA Funds.
            
            Should you wish to invest directly in a MBA Funds financial product referred to in the UCITS website you must only do so on the basis of a current prospectus (including any addenda thereto), application form and key investor information document (KIID) either downloaded from the UCITS website or provided by us in hard copy form.
            
            No guarantees or financial advice
            
            This UCITS website provides general information about MBA Funds only, it does not provide any financial product or investment advice. It should not be construed as a recommendation to invest in any particular financial product on the UCITS website. 
            
            Neither Maple-Brown Abbott, MBA Funds nor their associated parties make any representation nor give any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any financial product shown on this UCITS website. Investment is subject to certain risks. Possible risks could include delays in repayment and loss of income or capital invested. 
            
            This UCITS website does not take into account the investment objectives, financial situation or particular needs of any person and should not be used as the basis for making investment, financial or other decisions. We do not give advice in relation to any particular investment, security or financial product offered by MBA Funds or any associated parties. Before making an investment decision, you should obtain and consider the relevant prospectus (including any addenda thereto) and KIID, and you should seek independent advice and consider whether an investment is appropriate in light of your particular investment needs, objectives and financial circumstances. 
            
            Past performance
            
            Past performance is not a reliable indicator of future performance. Investment is subject to certain risks including the loss of capital invested. All asset values are based on our most recent valuations. As pricing frequencies and valuation methodologies differ for the various types of assets, the asset values shown may not be current and, therefore, you shouldn’t rely on them as the basis for trading investments in your account. Returns are volatile and may fluctuate quickly and significantly.
            
            Changes in exchange rates may have an adverse effect on the value price or income of a sub fund of MBA Funds or any class thereof.
            
            Market highlights
            
            The views expressed in any articles are the author’s alone. They should not be otherwise attributed. These views are current as at the date of production and can change day to day. Maple-Brown Abbott and/or MBA Funds may or may not hold securities mentioned. 
            
            Intellectual property rights, trademarks and copyright
            
            Copyright, trademarks, intellectual property rights, database rights and all similar rights in this UCITS website and the information contained in it are owned by Maple-Brown Abbott, MBA Funds or their associated parties. You may use the information on this UCITS website and reproduce it in hardcopy for your own personal reference only provided that you do not remove any copyright notices, disclaimers or any Maple-Brown Abbott trademarks or logos. Except for this purpose or as permitted by law, none of the information on this UCITS website may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the express written consent of Maple-Brown Abbott or, in the case of third party material, from the owner of the copyright in that material.
            
            Links to and from other websites
            
            The UCITS website may contain links to other websites. Neither Maple-Brown Abbott, MBA Funds, nor any associated party make any representation or warranty as to the accuracy, quality, currency or any other aspect of the information contained in those linked websites. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott, MBA Funds or any associated party of the goods or services offered on that other website or the information contained in that other website. You agree that you will not create any link to any page within the UCITS website without Maple-Brown Abbott's express written permission.
            
            Privacy, records and cookies 
            
            You authorise us to keep records of your access to the UCITS website and to utilise cookies, including placing cookies on your computer, during your access to the UCITS website.
            
            You acknowledge and agree that the collection, disclosure, processing and/or use of information about you from accessing the UCITS website will be subject to the Data Privacy Statement.
            
            Governing law
            
            These UCITS Terms are governed by the laws applicable in Ireland and each party irrevocably submits to the non-exclusive jurisdiction of the courts of Ireland.
            
            Internet
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accept no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.

           Acceptance of UCITS terms and conditions

            This section of the website (UCITS website) has been prepared by Maple-Brown Abbott Limited (ABN 73 001 208 564 AFSL 237296 ) (Maple-Brown Abbott or we) on behalf of Maple-Brown Abbott Funds plc (MBA Funds). The UCITS website is owned and operated by Maple-Brown Abbott. By accessing the UCITS website you agree to the following terms and conditions (the UCITS Terms) and acknowledge that you have read and understood them. In addition to these UCITS Terms, you agree that your access to this UCITS website is also subject to any other notices, disclaimers or statements contained on this UCITS website.
            
            Maple-Brown Abbott may make changes to the UCITS Terms from time to time without prior notice to you. By continuing to access the UCITS website, you are deemed to have accepted such changes and that Maple-Brown Abbott has no obligation to notify you of any such changes.
            
            Restrictions on information
            
            Access to the UCITS website may be restricted by law in certain jurisdictions. Neither Maple-Brown Abbott nor MBA Funds make any representation that the use of this information is permitted in locations other than Ireland or jurisdictions in which MBA Funds is registered for sale. 
            
            This information on the UCITS website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject Maple-Brown Abbott, MBA Funds or their associated parties to any registration or other requirement within that jurisdiction or country.
            
            When using the UCITS website, you are responsible for complying with all applicable local, national and international laws and regulations, including those related to data privacy and intellectual property.  It may be illegal to access or download the information contained in the UCITS website in certain jurisdictions and we disclaim all responsibility if you access or download any information in breach of any law or regulation applicable to you or in the place that you access the UCITS website.
            
            No U.S. Persons
            
            The information on this UCITS website is not available to US persons, as defined under Regulation S of the U.S. Securities Act of 1933, as amended (US Person). As such by accepting these UCITS Terms you represent and warrant that you: (i) are not a US Person; (ii) are not acting on for the account or benefit of any US Person; and (iii) will not provide or otherwise make available any information herein to any US Person.
            
            Limit of liability
            
            The information is believed to be accurate at the time of compilation and is provided by Maple-Brown Abbott and MBA Funds in good faith. However, the use of the UCITS website is at your sole risk. Neither Maple-Brown Abbott nor MBA Funds make any representation or warranty as to the quality, completeness, accuracy, reliability, timeliness or currency of information contained in the UCITS website.
            
            To the full extent permitted by law, Maple-Brown Abbott, MBA Funds and their associated parties exclude all liability for any direct or indirect loss or damage arising in any way from errors or omissions in the information in the UCITS website, and exclude all responsibilities for any direct or indirect loss or damage arising in any way as a result of any person using the UCITS website or relying on, using or downloading anything from the UCITS website.
            
            Liability for negligence, breach of contract, or contravention of any law as a result of a failure to provide this information, or any part of it, or for any problems with this information, which cannot be lawfully excluded, is limited, at Maple-Brown Abbott’s and/ or MBA Funds’ option, and to the maximum extent permitted by law, to resupplying this information or any part of it to you, or paying for the resupply of this information or any part of it to you.
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accepts no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.
            
            Current Prospectus
            
            The provision of material on the UCITS website is not an invitation to enter into any legal agreement of any kind. No statement or information in the UCITS website constitutes an offer, recommendation, invitation to invest in any investments, securities or financial products of MBA Funds.
            
            Should you wish to invest directly in a MBA Funds financial product referred to in the UCITS website you must only do so on the basis of a current prospectus (including any addenda thereto), application form and key investor information document (KIID) either downloaded from the UCITS website or provided by us in hard copy form.
            
            No guarantees or financial advice
            
            This UCITS website provides general information about MBA Funds only, it does not provide any financial product or investment advice. It should not be construed as a recommendation to invest in any particular financial product on the UCITS website. 
            
            Neither Maple-Brown Abbott, MBA Funds nor their associated parties make any representation nor give any guarantee as to the future performance or success of, the rate of income or capital return from, recovery of money invested in, or income tax or other taxation consequences of, any financial product shown on this UCITS website. Investment is subject to certain risks. Possible risks could include delays in repayment and loss of income or capital invested. 
            
            This UCITS website does not take into account the investment objectives, financial situation or particular needs of any person and should not be used as the basis for making investment, financial or other decisions. We do not give advice in relation to any particular investment, security or financial product offered by MBA Funds or any associated parties. Before making an investment decision, you should obtain and consider the relevant prospectus (including any addenda thereto) and KIID, and you should seek independent advice and consider whether an investment is appropriate in light of your particular investment needs, objectives and financial circumstances. 
            
            Past performance
            
            Past performance is not a reliable indicator of future performance. Investment is subject to certain risks including the loss of capital invested. All asset values are based on our most recent valuations. As pricing frequencies and valuation methodologies differ for the various types of assets, the asset values shown may not be current and, therefore, you shouldn’t rely on them as the basis for trading investments in your account. Returns are volatile and may fluctuate quickly and significantly.
            
            Changes in exchange rates may have an adverse effect on the value price or income of a sub fund of the MBA Funds or any class thereof.
            
            Market highlights
            
            The views expressed in any articles are the author’s alone. They should not be otherwise attributed. These views are current as at the date of production and can change day to day. Maple-Brown Abbott and/or MBA Funds may or may not hold securities mentioned. 
            
            Intellectual property rights, trademarks and copyright
            
            Copyright, trademarks, intellectual property rights, database rights and all similar rights in this UCITS website and the information contained in it are owned by Maple-Brown Abbott, MBA Funds or their associated parties. You may use the information on this UCITS website and reproduce it in hardcopy for your own personal reference only provided that you do not remove any copyright notices, disclaimers or any Maple-Brown Abbott trademarks or logos. Except for this purpose or as permitted by law, none of the information on this UCITS website may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the express written consent of Maple-Brown Abbott or, in the case of third party material, from the owner of the copyright in that material.
            
            Links to and from other websites
            
            The UCITS website may contain links to other websites. Neither Maple-Brown Abbott, MBA Funds, nor any associated party make any representation or warranty as to the accuracy, quality, currency or any other aspect of the information contained in those linked websites. A link to another website is not and should not be construed as an endorsement or recommendation by Maple-Brown Abbott, MBA Funds or any associated party of the goods or services offered on that other website or the information contained in that other website. You agree that you will not create any link to any page within the UCITS website without Maple-Brown Abbott's express written permission.
            
            Privacy, records and cookies 
            
            You authorise us to keep records of your access to the UCITS website and to utilise cookies, including placing cookies on your computer, during your access to the UCITS website.
            
            You acknowledge and agree that the collection, disclosure, processing and/or use of information about you from accessing the UCITS website will be subject to the Data Privacy Statement.
            
            Governing law
            
            These UCITS Terms are governed by the laws applicable in Ireland and each party irrevocably submits to the non-exclusive jurisdiction of the courts of Ireland.
            
            Internet
            
            Errors, omissions, interruptions and delays of services may occur at any time on the internet as it is not a totally reliable or secure medium of communication. Maple-Brown Abbott and MBA Funds accept no liability for the consistency, security and confidentiality of any information sent over the internet and any transmissions over the internet are entirely at the user's risk.

I agree to the terms and conditions

Seeking Australian small cap exposure?

Australian small caps at an inflection point

About the Maple-Brown Abbott Australian Small Companies Fund

Watch our capability video

Our investment philosophy

Find out more

All weather portfolio

Capture ratios – upside and downside

Average monthly performance in rising markets

Average monthly performance in falling markets

Fund rating and platform availability

Platform availability

Morningstar Medalist Rating(TM) Assigned as of 08/01/25 Analyst Driven % 100 Data Coverage % 100

Fund Maple-Brown Abbott Australian Small Companies received a Morningstar Medalist Rating(TM) of ‘Silver’ on 08/01/25.

Fund performance^

A team of experienced and dedicated investment professionals.

Co-Portfolio Manager, Australian Small Companies

Phillip Hudak

Phillip

Co-Portfolio Manager, Australian Small Companies

Matt Griffin

Matt

Investment Analyst, Australian Small Companies

William Hanna

William

ESG Investment Analyst

Ayesha Azeem

Ayesha

Contact us

Alternatively, contact

Subscribe to receive Investment Insights

Seeking Australian
small cap exposure?

Morningstar Medalist Rating(TM)
Assigned as of 08/01/25
Analyst Driven % 100
Data Coverage % 100

A team of experienced and dedicated
investment professionals.